ArticleDrug delivery2018

Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.

Yuki Minayoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.